MTOR and cancer: PRL-3 has specifically been implicated in activation of acknowledged cancer progression pathways like phosphatidylinositol-3 kinase[42], regulating mTOR activation[43], Src tyrosine protein kinase[44, 45], epidermal growth factor receptor (EGFR)[46], and ERK[15].